Bio / Bio Monthly (May 2026): PeptAI Ignition Sale, BIO on Robinhood, veBIO Staker Rewards

EcosystemJune 3, 2026

Bio Monthly (May 2026): PeptAI Ignition Sale, BIO on Robinhood, veBIO Staker Rewards

Highlights from May in the Biosphere 🌐‍PeptAI Ignition Sale: The PeptAI Ignition Sale successfully closed 32x+ oversubscribed, with 1.6M+ USDC committed by 1.4K+ participants. veBIO staker reward claims are now live on app.bio.xyz for PEPTAI. Next up: first on-chain wet-lab attestation via Molecule Labs in Q2, and...

By Bio Community, Eda Arslan

Bio Monthly (May 2026): PeptAI Ignition Sale, BIO on Robinhood, veBIO Staker Rewards

Highlights from May in the Biosphere 🌐

‍PeptAI Ignition Sale: The PeptAI Ignition Sale successfully closed 32x+ oversubscribed, with 1.6M+ USDC committed by 1.4K+ participants. veBIO staker reward claims are now live on app.bio.xyz for PEPTAI. Next up: first on-chain wet-lab attestation via Molecule Labs in Q2, and a GLP-1R Gen 1 library in Q3.‍
BIO on Robinhood: BIO is now tradable on @RobinhoodApp, bringing DeSci to one of the world's most widely used retail trading platforms.‍
BIOS Live Demo: We hosted a live demo of upcoming BIOS features including including new biotech tool integrations, image segmentation, and an in-house robotics program to close the full autonomous loop from receptor to wet-lab result with more on the way.‍
Ecosystem Updates include: VitaDAO launching VitaApp in private alpha with Aubrai's longevity AI built in and Cyclarity presenting first human evidence that arterial plaque driver 7-ketocholesterol can be safely excreted, AthenaDAO launching the Longitudinal Menopause Project, HairDAO filing their 10th patent on the back of first human data for MINX, SpineDAO presenting at NSpine in Corsica in front of 80+ spine surgeons, and DeSci Berlin returning June 18–19 during @BerBlockWeek. RSVP now.

PeptAI Ignition Sale: Autonomous Agents for Peptide Drug Discovery

Bio's most recent Ignition Sale successfully closed 32x+ oversubscribed, with 1.6M+ USDC committed by 1.4K+ participants.

‍VitaDAO (@vitadao) - Cyclarity presented Phase 1 results for UDP-003 at AHA Vascular Discovery, showing the first human evidence that 7-ketocholesterol (a driver of arterial plaque) can be safely excreted, with Phase 2 on plaque regression planned for 2026. They launched VitaApp in private alpha, their first consumer app with @Aubrai_ longevity AI built in. Aubrai is also closing a native AI-to-wet-lab integration, generating hypotheses and paying scientists when results land. VitaRNA's lead candidate ARTAN-102 hit 350x liver expression in vivo, with primate toxicity next. Portfolio companies continue to advance: Gero signed with Roche's Chugai for up to $250M in milestones, and Rubedo reported positive Phase 1 readouts for RLS-1496, the first GPX4 modulator ever dosed in humans, with Phase 2a ahead. VitaLabs is being rebuilt as an AI-native longevity venture studio, with cohort 1 capped at 3 projects.
‍FOXO3 (by @vitadao) - identified six ASOs capable of more than doubling production of the long, active form of the FOXO3 protein in primary human disc cells which is a key step toward RNA drugs that could treat degenerative disc disease. The team has established cell cultures, confirmed ASO delivery without nanocarriers, and built a damaged disc cell model for functional testing. A community call is scheduled for July 2026, with a preliminary data update coming May 26.
‍AthenaDAO (@athenabiorg) - released their Longitudinal Menopause Project, building a dataset for sex-specific research and recruiting women aged 40–55 in San Francisco, Santa Barbara, or San Diego. Register here.
‍CerebrumDAO (@Cerebrum_DAO) - partnered with Waves, a browser-based brain health platform with an AI coach called Celeste, built on a cognitive neuroscience methodology developed at UT Dallas Center for BrainHealth. Try it for free. They also hosted an AMA session on science updates.
‍HairDAO (@HairDAO_) - released first human pharmacokinetic data for MINX, their DeSci funded and first AI-designed 5mg oral minoxidil lipid-matrix capsule. Not yet proof of better efficacy or fewer side effects, but a strong early signal of differentiated behavior. HairDAO filed their 10th provisional patent on the back of this data.
‍SpineDAO (@Spine_DAO) - presented at NSpine Innovative Spine Education in Bastia, Corsica, appearing on a podium slide during a clinical talk in front of 80+ spine surgeons from around the world.‍
Quantum Biology DAO (@QuantumBioDAO) - launched a new QBI-DAO Slack channel run by the Quantum Biology Institute, serving as a central hub for DAO community updates including reports, publications, events, and financial updates, part of their commitment to building in public and keeping science open and transparent.‍
ValleyDAO (@valley_dao) - released a new Proof of DeSci episode on how to get your first DeSci project funded. Listen to the full episode.
DeSci Berlin is back for its 5th edition on June 18-19, during @BerBlockWeek with speakers from @Molecule_sci, @peptai_, @foresightinst and more! RSVP now.
Bio hosted a livestream with the founders of @peptai_ and ALIVE discussing their projects and roadmaps.‍
@peptai_ hosted a livestream with the team breaking down how the agent fleet works and what's currently running in the pipeline.‍
@peptai_ is hiring a founding cocktologist, a scientist who will design novel peptide candidates and pilot the autonomous agent fleet that validates them. Apply now!